ey0019.14-10 | Risk and Outcome | ESPEYB19
DR Jr Jacobs , JG Woo , AR Sinaiko , SR Daniels , J Ikonen , M Juonala , N Kartiosuo , T Lehtimaki , CG Magnussen , JSA Viikari , N Zhang , LA Bazzano , TL Burns , RJ Prineas , J Steinberger , EM Urbina , AJ Venn , OT Raitakari , T Dwyer
ey0017.4-3 | Important for clinical practice | ESPEYB17
Y Masunaga , T Inoue , K Yamoto , Y Fujisawa , Y Sato , Y Kawashima-Sonoyama , N Morisada , K Iijima , Y Ohata , N Namba , H Suzumura , R Kuribayashi , Y Yamaguchi , H Yoshihashi , M Fukami , H Saitsu , M Kagami , T Ogata
ey0017.11-3 | New Genetic Findings | ESPEYB17
LA Lotta , J Mokrosinski , E Mendes de Oliveira , C Li , SJ Sharp , J Luan , B Brouwers , V Ayinampudi , N Bowker , N Kerrison , V Kaimakis , D Hoult , ID Stewart , E Wheeler , FR Day , JRB Perry , C Langenberg , NJ Wareham , IS Farooqi
ey0016.8-11 | New Genes | ESPEYB16
DB Hawcutt , B Francis , DF Carr , AL Jorgensen , P Yin , N Wallin , N O'Hara , EJ Zhang , KM Bloch , A Ganguli , B Thompson , L McEvoy , M Peak , AA Crawford , BR Walker , JC Blair , J Couriel , RL Smyth , M Pirmohamed
ey0016.9-15 | Biologic Agents and Growth in Chronic Inflammatory Diseases | ESPEYB16
KN Bharucha , HI Brunner , I Calvo Penades , I Nikishina , N Rubio-Perez , S Oliveira , K Kobusinska , H Schmeling , F Sztajnbok , F Weller-Heinemann , E Zholobova , F Zulian , R Allen , J Chaitow , J Frane , C Wells , N Ruperto , F De Benedetti
ey0015.6-16 | When should an extensive genetic investigation be performed? | ESPEYB15
M Ollivier , F Paris , P Philibert , S Garnier , A Coffy , N Fauconnet-Servant , M Haddad , JM Guys , R Reynaud , A Faure , T Merrot , K Wagner , J Bréaud , JS Valla , E Dobremez , L Gaspari , JP Daures , C Sultan , N Kalfa
ey0015.8-6 | Important for Clinical Practice | ESPEYB15
DB Hawcutt , B Francis , DF Carr , AL Jorgensen , P Yin , N Wallin , N O'Hara , EJ Zhang , KM Bloch , A Ganguli , B Thompson , L McEvoy , M Peak , AA Crawford , BR Walker , JC Blair , J Couriel , RL Smyth , M Pirmohamed
ey0015.9-1 | Late consequences of tumour therapy: prevention and monitoring | ESPEYB15
MJ Ehrhardt , JT Sandlund , N Zhang , W Liu , KK Ness , N Bhakta , W Chemaitilly , KR Krull , TM Brinkman , DB Crom , L Kun , SC Kaste , GT Armstrong , DM Green , K Srivastava , LL Robison , MM Hudson , DA Mulrooney
ey0015.10-13 | Comorbidities – short and long-term complications | ESPEYB15
ME Craig , N Prinz , CT Boyle , FM Campbell , TW Jones , SE Hofer , JH Simmons , N Holman , E Tham , E Fröhlich-Reiterer , S DuBose , H Thornton , B King , DM Maahs , RW Holl , JT Warner
ey0015.13-6 | How does paediatric endocrinology and diabetes fit in the global initiatives? | ESPEYB15
S Sayed , W Cherniak , M Lawler , SY Tan , W El Sadr , N Wolf , S Silkensen , N Brand , LM Looi , SA Pai , ML Wilson , D Milner , J Flanigan , KA Fleming